Tuesday, July 24, 2018

On the Record

"By allowing more communication of clinical and economic information before approval, the manufacturer can get out in front, and payers can make a more informed decision."

— Jeremy Schafer, Pharm.D., senior vice president at Precision for Value, tells AIS Health about the FDA's guidance on health care economic information.

No comments:

Post a Comment